Page last updated: 2024-09-05

cypripedin and Cancer of Lung

cypripedin has been researched along with Cancer of Lung in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pongrakhananon, V; Sritularak, B; Treesuwan, S; Wattanathamsan, O1
Chanvorachote, P; Pongrakhananon, V; Sritularak, B; Treesuwan, S1

Other Studies

2 other study(ies) available for cypripedin and Cancer of Lung

ArticleYear
Cypripedin, a phenanthrenequinone from Dendrobium densiflorum, sensitizes non-small cell lung cancer H460 cells to cisplatin-mediated apoptosis.
    Journal of natural medicines, 2018, Volume: 72, Issue:2

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cisplatin; Humans; Lung Neoplasms; Naphthoquinones

2018
Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling.
    Scientific reports, 2018, 05-22, Volume: 8, Issue:1

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Lung Neoplasms; Naphthoquinones; Neoplasm Metastasis; Proto-Oncogene Proteins c-akt; Signal Transduction; Tumor Cells, Cultured

2018